H-ras codon 12 mutation in cervical dysplasia - PubMed (original) (raw)
H-ras codon 12 mutation in cervical dysplasia
L Van Le et al. Gynecol Oncol. 1993 May.
Abstract
A mutation in codon 12 of the H-ras oncogene has been implicated in the pathogenesis of cervical cancer. To determine if mutational activation of H-ras is an early event in carcinogenesis, we looked for the presence of codon 12 H-ras mutation in precancerous cervical dysplasia. We analyzed cervical DNA from 63 normal patients and 72 patients with biopsy-proven cervical dysplasia [CIN I (48), CIN II (9), CIN III (15)]. HPV typing was performed on these samples by Viratype and analysis and polymerase chain reaction (PCR). To detect H-ras codon 12 mutation, DNA was isolated and amplified by PCR with primers for H-ras. A unique restriction site for MspI contained within the wild-type ras PCR product allows discrimination between unmutated and mutated sequences. Restriction enzyme analysis with MspI was performed on PCR products to distinguish between wild-type and mutated sequences. HPV 16 or 18 was present in 33% of CIN I, 56% of CIN II, and all CIN III samples. No codon 12 mutations were detected in any sample. We conclude that while HPV is associated with cervical dysplasia and its prevalence increases in more advanced lesions, it is unlikely that H-ras codon 12 mutations are an early occurrence in the progression of precancerous lesions to cervical carcinoma.
Similar articles
- Molecular analysis of ras oncogenes in CIN III and in stage I and II invasive squamous cell carcinoma of the uterine cervix.
O'Leary JJ, Landers RJ, Silva I, Uhlmann V, Crowley M, Healy I, Luttich K. O'Leary JJ, et al. J Clin Pathol. 1998 Aug;51(8):576-82. doi: 10.1136/jcp.51.8.576. J Clin Pathol. 1998. PMID: 9828814 Free PMC article. - [Ha-ras and p53 gene mutations scanned by PCR-SSCP in premalignant and malignant lesions of the uterine cervix associated with human papillomavirus].
Alonio LV, Dalbert D, Picconi MA, Cervantes Vazquez G, García Carrancá A, Distefano AL, Mural J, Bartt O, Bazan G, Teyssie AR. Alonio LV, et al. Medicina (B Aires). 2000;60(6):895-901. Medicina (B Aires). 2000. PMID: 11436698 Spanish. - Identification of H, K, and N-ras point mutations in stage IB cervical carcinoma.
Grendys EC Jr, Barnes WA, Weitzel J, Sparkowski J, Schlegel R. Grendys EC Jr, et al. Gynecol Oncol. 1997 May;65(2):343-7. doi: 10.1006/gyno.1997.4649. Gynecol Oncol. 1997. PMID: 9159349 - Human papillomavirus and mutated H-ras oncogene in cervical carcinomas and pathological negative pelvic lymph nodes: a retrospective follow-up.
Landro ME, Dalbert D, Picconi MA, Cúneo N, González J, Vornetti S, Bazán G, Mural J, Basiletti J, Teyssié AR, Alonio LV. Landro ME, et al. J Med Virol. 2008 Apr;80(4):694-701. doi: 10.1002/jmv.21076. J Med Virol. 2008. PMID: 18297710 - Mutations of K-ras oncogene and absence of H-ras mutations in squamous cell carcinomas of the lung.
Vachtenheim J, Horáková I, Novotná H, Opáalka P, Roubková H. Vachtenheim J, et al. Clin Cancer Res. 1995 Mar;1(3):359-65. Clin Cancer Res. 1995. PMID: 9815992
Cited by
- Cervical keratinocytes containing stably replicating extrachromosomal HPV-16 are refractory to transformation by oncogenic H-Ras.
Berger KL, Barriga F, Lace MJ, Turek LP, Zamba GJ, Domann FE, Lee JH, Klingelhutz AJ. Berger KL, et al. Virology. 2006 Dec 5-20;356(1-2):68-78. doi: 10.1016/j.virol.2006.07.039. Epub 2006 Aug 30. Virology. 2006. PMID: 16945398 Free PMC article. - Molecular analysis of ras oncogenes in CIN III and in stage I and II invasive squamous cell carcinoma of the uterine cervix.
O'Leary JJ, Landers RJ, Silva I, Uhlmann V, Crowley M, Healy I, Luttich K. O'Leary JJ, et al. J Clin Pathol. 1998 Aug;51(8):576-82. doi: 10.1136/jcp.51.8.576. J Clin Pathol. 1998. PMID: 9828814 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous